7 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 7 |
| Phase 2 | 1 | Terminated 1 |
Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial Insulin - Hyperglycemia | Phase 3 | Terminated | University of Sao Paulo | 500 | 2017-01-01 | 2022-11-04 |
| Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin Metformin, Sugar pill - Insulin Resistance, Hypermetabolism | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 36 | 2012-11-01 | 2019-11-29 |
| Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin Human regular insulin, Insulin lispro, Insulin glargine - Hyperglycemia | Phase 3 | Terminated | Eli Lilly and Company | 16 | 2011-03-01 | 2012-11-13 |
| Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia vitamin D - Coronary Artery Disease, Postprandial Hyperglycemia | Phase 3 | Terminated | Medical University of Graz | 22 | 2010-06-01 | 2015-04-17 |
| Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog ) - Diabetes Mellitus | Phase 3 | Terminated | Florida Atlantic University | 300 | 2007-03-01 | 2016-02-03 |
| Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes Rimonabant, Placebo (for Rimonabant) - Prediabetic State | Phase 3 | Terminated | Sanofi | 2420 | 2006-05-01 | 2016-05-18 |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) Insulin Glargine, Insulin Aspart - Leukemia, Lymphoma | Phase 3 | Terminated | M.D. Anderson Cancer Center | 52 | 2004-04-01 | 2015-06-03 |
Diabetes Mellitus (2) · Insulin Resistance (2) · Burkitt Lymphoma (1) · Burns (1) · Coronary Artery Disease (1) · Diabetes Complications (1) · Glucose Intolerance (1) · Hypoglycemia (1) · Leukemia (1) · Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Prediabetic State (1) · Vitamin D Deficiency (1)
Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Endocrine System Diseases (3) · Hyperinsulinism (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Avitaminosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · DNA Virus Infections (1) · Deficiency Diseases (1) · Diabetes Mellitus (1) · Epstein-Barr Virus Infections (1) · Heart Diseases (1)
Insulin (2) · Insulin Aspart (2) · Insulin Glargine (2) · Glycemic Control (1) · Insulin Lispro (1) · Insulin, Regular, Human (1) · Metformin (1) · Rimonabant (1) · Sugars (1) · Vitamin D (1)
Eli Lilly and Company (1) · Florida Atlantic University (1) · M.D. Anderson Cancer Center (1) · Medical University of Graz (1) · Sanofi (1) · The University of Texas Medical Branch, Galveston (1) · University of Sao Paulo (1)
United States (5) · Austria (1) · Brazil (1)
Betty Tuller, PhD (1) · David N Herndon, MD (1) · Eduesley Santana Santos, Ph.D (1) · Khanh Vu, MD (1) · Thomas R. Pieber, MD (1)
PMID 16075050, PMID 16738506, PMID 18184958, PMID 19318384, PMID 19559824, PMID 19636533, PMID 22658895, PMID 24401049, PMID 8993292